Solventum (SOLV) P/E (2024 - 2026)
Solventum (SOLV) P/E from Mar 26, 2024 to Jul 21, 2026. The TTM Solventum (SOLV) P/E is 9.52. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Solventum (SOLV)
| Year | P/E | Change |
|---|---|---|
| 2026 | 9.52 | +7.81% |
| 2025 | 8.83 | -62.93% |
| 2024 | 23.82 | N/A |
Comparison Solventum (SOLV) P/E with competitors
Solventum (SOLV) P/E is 9.52.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -97.65% |
| EMBC | Embecta Corp | 1.69 | -82.25% |
| ZJYL | Jin Medical International Ltd | 12.75 | +33.90% |
| PDEX | Pro-Dex Inc (co) | 15.22 | +59.87% |
| RMD | Resmed Inc | 19.04 | +100.06% |
| UTMD | Utah Medical Products Inc | 20.76 | +118.07% |
| ATR | Aptargroup Inc | 21.65 | +127.39% |
| ALGN | Align Technology Inc | 30.29 | +218.20% |
| HOLX | Hologic Inc | 30.86 | +224.21% |
| MMSI | Merit Medical Systems Inc | 31.15 | +227.17% |
| STVN | Stevanato Group Spa | 31.25 | +228.31% |
| LMAT | Lemaitre Vascular Inc | 36.34 | +281.73% |
| ALC | Alcon Inc | 41.51 | +336.09% |
| ISRG | Intuitive Surgical Inc | 46.43 | +387.69% |
| BDX | Becton Dickinson & Company | 46.93 | +392.99% |
| WST | West Pharmaceutical Services Inc | 47.41 | +397.99% |
| NEPH | Nephros Inc | 50.00 | +425.18% |
| COO | Cooper Companies Inc | 58.98 | +519.53% |
| NNNN | Anbio Biotechnology - Class A | 62.20 | +553.37% |
| NVST | Envista Holdings Corp | 64.66 | +579.25% |
| BAX | Baxter International Inc | 72.66 | +663.21% |
| ICUI | ICU Medical Inc | 84.82 | +790.99% |
| RGEN | Repligen Corp | 162.20 | +1603.78% |
| WRBY | Warby Parker Inc - Class A | 318.30 | +3243.54% |